In vitro study demonstrates improved cell behavior and biocompatibility with enhanced metabolic activity on zirconia surfaces with nonthermal plasma treatment.
Zirconia is widely used for customized implant abutments owing to its esthetics, strength, and biocompatibility; however, the optimal surface modification for soft-tissue sealing and bone metabolic remains uncertain. This study evaluated how glass–ceramic spray deposition (GCSD), with or without handheld nonthermal plasma (HNP), alters zirconia surface physiochemistry and cellular responses. Field-emission scanning electron microscopy/energy-dispersive X-ray spectroscopy, surface roughness (Ra), wettability, and surface free energy (SFE) were measured. Human osteoblast-like cells (MG-63) and human gingival fibroblasts (HGF-1) were used to assess attachment and spreading, metabolic activity, cytotoxicity, and inflammatory response (tumor necrosis factor-α, TNF-α) (α = 0.05). GCSD produced an interlaced rod- and needle-like glass–ceramic layer, significantly increasing Ra and hydrophilicity. HNP further reduced surface contaminants, increased SFE, and enhanced wettability. The combination of GCSD and HNP yielded the greatest attachment and spreading for both cell types, without increases in cytotoxicity or TNF-α. GCSD with HNP creates a hydrophilic, micro-textured, chemically activated zirconia surface that maintains biocompatibility while promoting early attachment and bone metabolic activity, supporting its application for zirconia implant abutments.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: